Meclizine HCL 25 mg
- Product NDC
- 71335-1607
- Requested package NDC
- 71335-1607-8
- 11-digit product format
- 713351607
- Labeler code
- 71335
- Product ID
- 71335-1607_afe16058-294e-4e4f-9a1b-4af4e96eedea
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Meclizine HCL
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- M009
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2015-11-01
- Substance
- MECLIZINE HYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Antiemetic [EPC], Emesis Suppression [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 71335-1607 | 71335-1607-8 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 834df4deac94… | adcc014656a3… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 71335-1607 | 71335-1607-8 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Meclizine HCL 25 mg
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MECLIZINE HYDROCHLORIDE | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| HDP7W44CIO | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 995632 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| d1c58a74-5455-4a07-bcb6-cc114032ed12 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 71335-1607-0 | 2024-05-21 | Meclizine HCL 25 mg |
| 71335-1607-1 | 2024-05-21 | Meclizine HCL 25 mg |
| 71335-1607-2 | 2024-05-21 | Meclizine HCL 25 mg |
| 71335-1607-3 | 2024-05-21 | Meclizine HCL 25 mg |
| 71335-1607-4 | 2024-05-21 | Meclizine HCL 25 mg |
| 71335-1607-5 | 2024-05-21 | Meclizine HCL 25 mg |
| 71335-1607-6 | 2024-05-21 | Meclizine HCL 25 mg |
| 71335-1607-7 | 2024-05-21 | Meclizine HCL 25 mg |
| 71335-1607-8 | 2024-05-21 | Meclizine HCL 25 mg |
| 71335-1607-9 | 2024-05-21 | Meclizine HCL 25 mg |
| 71335-1607-0 | 2024-01-30 | Meclizine HCL 25 mg |
| 71335-1607-1 | 2024-01-30 | Meclizine HCL 25 mg |
| 71335-1607-2 | 2024-01-30 | Meclizine HCL 25 mg |
| 71335-1607-3 | 2024-01-30 | Meclizine HCL 25 mg |
| 71335-1607-4 | 2024-01-30 | Meclizine HCL 25 mg |
| 71335-1607-5 | 2024-01-30 | Meclizine HCL 25 mg |
| 71335-1607-6 | 2024-01-30 | Meclizine HCL 25 mg |
| 71335-1607-7 | 2024-01-30 | Meclizine HCL 25 mg |
| 71335-1607-8 | 2024-01-30 | Meclizine HCL 25 mg |
| 71335-1607-9 | 2024-01-30 | Meclizine HCL 25 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-1607-0 | Meclizine HCL 25 mg | 120 in 1 BOTTLE | TABLET | 120 | 5 | |
| 71335-1607-1 | Meclizine HCL 25 mg | 30 in 1 BOTTLE | TABLET | 30 | 5 | |
| 71335-1607-2 | Meclizine HCL 25 mg | 20 in 1 BOTTLE | TABLET | 20 | 5 | |
| 71335-1607-3 | Meclizine HCL 25 mg | 25 in 1 BOTTLE | TABLET | 25 | 5 | |
| 71335-1607-4 | Meclizine HCL 25 mg | 40 in 1 BOTTLE | TABLET | 40 | 5 | |
| 71335-1607-5 | Meclizine HCL 25 mg | 60 in 1 BOTTLE | TABLET | 60 | 5 | |
| 71335-1607-6 | Meclizine HCL 25 mg | 90 in 1 BOTTLE | TABLET | 90 | 5 | |
| 71335-1607-7 | Meclizine HCL 25 mg | 8 in 1 BOTTLE | TABLET | 8 | 5 | |
| 71335-1607-8 | Meclizine HCL 25 mg | 14 in 1 BOTTLE | TABLET | 14 | 5 | |
| 71335-1607-9 | Meclizine HCL 25 mg | 10 in 1 BOTTLE | TABLET | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-1607 | MECLIZINE HCL 25 MG (MECLIZINE HCL) TABLET [BRYANT RANCH PREPACK] | 5 | Current NDC, Legacy NDC, 10 package rows | 20250402_d1c58a74-5455-4a07-bcb6-cc114032ed12.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dramamine Orange | DIMENHYDRINATE | Medtech Products Inc. | 76166156-bce1-492f-833e-6bbd07859c3f | 2026-09-17 | Warnings | M009 |
| Pepto Nausea Motion Sickness | MECLIZINE HCL | THE PROCTER & GAMBLE MANUFACTURING COMPANY | 29a1bd1e-d0e0-478f-e063-6394a90ab0aa | 2026-09-10 | Warnings | M009 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | A-S Medication Solutions | 2518b0b6-35ab-49f4-936c-1eafea04b466 | 2026-09-09 | Warnings | M009 |
| Dramamine Less Drowsy | MECLIZINE HYDROCHLORIDE | Medtech Products Inc. | fa6a0969-7427-4b87-bc04-a2792665c218 | 2026-09-04 | Warnings | M009 |
| Less Drowsy Motion Sickness Relief | MECLIZINE HCL | Wal-Mart Stores Inc | 277a6266-e641-4621-bbb9-64195d51b66a | 2026-08-28 | Warnings | M009 |
| Nausea Relief | MECLIZINE HCL | WALMART INC. | 8010741e-61b2-4c1f-9f0e-21612878fa0e | 2026-08-28 | Warnings | M009 |
| Motion Sickness | MECLIZINE HCL | H E B | 9837e9af-c542-4c0f-be33-94927d67c6a7 | 2026-08-21 | Warnings | M009 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | Bryant Ranch Prepack | cd82fca9-a8dc-4545-8e64-b67d644832e7 | 2026-08-20 | Warnings | M009 |
| Motion Sickness | DIMENHYDRINATE | Strategic Sourcing Services LLC | be8f91d4-6e4f-4d47-93e9-7fb91160b7df | 2026-08-17 | Warnings | M009 |
| Motion Sickness Relief | DIMENHYDRINATE | Walgreen Company | ace7eba4-e033-48f5-8533-c3ea9dfc32b0 | 2026-08-12 | Warnings | M009 |
| Motion Sickness | MECLIZINE HCL | Strategic Sourcing Services LLC | 76fb6471-09b0-4c51-bacc-b3533b6aa971 | 2026-08-07 | Warnings | M009 |
| Motion Sickness Relief | DIMENHYDRINATE | Cardinal Health 110, LLC. DBA Leader | ce83a868-bdd8-4c77-9bc0-664133028f75 | 2026-08-06 | Warnings | M009 |
| Less Drowsy Formula Motion Sickness Relief | MECLIZINE HCL | Salado Sales, Inc. | 273235b0-dacc-4a95-91be-91e13a2c6d10 | 2026-08-05 | Warnings | M009 |
| Motion Sickness Relief | MECLIZINE HCL | L.N.K. International, Inc. | 8e1889de-fbef-44f1-bbfb-c68a78e6330c | 2026-07-30 | Warnings | M009 |
| Motion Sickness Relief | DIMENHYDRINATE | Chain Drug Marketing Association, Inc. | 00a327c6-6b86-4702-8c04-55c405c1404c | 2026-07-23 | Warnings | M009 |
| Pepto Motion Sickness | MECLIZINE HCL | THE PROCTER & GAMBLE MANUFACTURING COMPANY | 571e3eeb-ae9e-7054-e063-6394a90a2634 | 2026-07-21 | Warnings | M009 |
| Meclizine Hydrochloride | MECLIZINE HYDROCHLORIDE | Rugby Laboratories | b57f14a7-3852-03db-e053-2a95a90a80d6 | 2026-07-16 | Warnings | M009 |
| Motion Sickness | DIMENHYDRINATE | CVS Pharmacy | 0998947c-cfba-497e-bf7a-9c7f8fff1764 | 2026-07-16 | Warnings | M009 |
| Motion Sickness Relief | MECLIZINE HCL | Topco Associates, LLC | 307e3144-3b01-4bd0-9155-6b58fc4cab92 | 2026-07-09 | Warnings | M009 |
| Motion Sickness Relief | DIMENHYDRINATE | L.N.K. International, Inc. | 95aae32f-6b3f-469d-86a5-c201a53f862a | 2026-06-29 | Warnings | M009 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 995632 | meclizine HCl 25 MG Chewable Tablet | PSN | d1c58a74-5455-4a07-bcb6-cc114032ed12 | 5 |
| 995632 | meclizine hydrochloride 25 MG Chewable Tablet | SCD | d1c58a74-5455-4a07-bcb6-cc114032ed12 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 71335-1607-8 | 71335160708 | 14 TABLET in 1 BOTTLE (71335-1607-8) | 14 tablet | 2022-02-14 | 0000-00-00 | No | No | Current |